The Venture Codex Logo

The Venture Codex

Overview

Therapeutics company using genomics and machine learning for targeted medic

Total Raised

$128 M

Rounds

3

Links

Verticals

Biotechnology
Clinical Trials
Health Care
Health Diagnostics
Therapeutics

Investment History

  1. Series B

    Sep 2025

    $17M

  2. Series B

    Mar 2025

    $93M

  3. Equity

    May 2022

    $18M

Team

Cheng Zhang

Co-Founder, Chief Executive Officer

Marcel van der Brug

Co-Founder & Chief Scientific Advisor

Laura Carter

Chief Scientific Officer

Erik Karrer

VP Drug Discovery